Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Jianming Xu, Yanqi Wang, Zhijun Wu et al.|Journal of Clinical Oncology|2020Cited by 24
Cholestyramine alleviates bone and muscle loss in irritable bowel syndrome via regulating bile acid metabolismMing Chen, Peifu Tang, Wei Wei et al.|Cell Proliferation|2024Cited by 10